𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

✍ Scribed by Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Moxham; Ken Stein

Book ID
109079069
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
146 KB
Volume
13
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacoeconomic profile of paclitaxel a
Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma : A lifetime cost-effectiveness analysis
✍ Andrea Messori; Michele Cecchi; Paola Becagli; Sabrina Trippoli πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views

medullary recurrence in certain ethnic groups will be the field have read the article. I agree that there is no proof that all-trans retinoic acid (ATRA) therapy confirmed by further observation and analysis of recurrence in the large cooperative group studying APL. predisposes patients to the deve